Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 0 | 1,336 | 1,336 | 1,692 | -10,253 |
| Cost of Goods | 0 | 223 | 225 | 282 | -6,846 |
| Gross Profit | 0 | 1,113 | 1,111 | 1,410 | -3,407 |
| Operating Expenses | 7,700 | 6,338 | 6,920 | 7,076 | 6,183 |
| Operating Income | -7,700 | -5,002 | -5,584 | -5,384 | -10,436 |
| Other Income | -871 | -1,013 | -599 | -1,129 | -1,388 |
| Pre-tax Income | -8,571 | -6,015 | -6,183 | -6,513 | -11,824 |
| Net Income Continuous | -8,571 | -6,015 | -6,183 | -6,513 | -11,824 |
| Net Income Discontinuous | 81,471 | 2,195 | 1,112 | 541 | N/A |
| Net Income | $72,900 | $-3,820 | $-5,071 | $-5,972 | $-8,469 |
| EPS Basic Total Ops | 7.60 | -0.40 | -0.50 | -0.60 | -0.80 |
| EPS Basic Continuous Ops | -1.00 | -0.60 | -0.60 | -0.70 | -1.29 |
| EPS Basic Discontinuous Ops | 8.60 | 0.20 | 0.10 | 0.10 | N/A |
| EPS Diluted Total Ops | 7.60 | -0.40 | -0.50 | -0.60 | -0.80 |
| EPS Diluted Continuous Ops | -1.00 | -0.60 | -0.60 | -0.70 | -1.29 |
| EPS Diluted Discontinuous Ops | 8.60 | 0.20 | 0.10 | 0.10 | N/A |
| EBITDA(a) | $-7,029 | $-4,302 | $-4,866 | $-4,658 | $-9,602 |